Skip to main content
. 2017 May 18;8(31):51387–51401. doi: 10.18632/oncotarget.17988

Table 3. Multivariate Cox regression analysis of recurrence and overall survivals.

Overall survival Recurrence-free probability
Characteristic n RR (95% CI) P value RR (95% CI) P value
pT stage 0.164* 0.128*
 pT1 10 1.00 1.00
 pT2 22 3.62 (0.51–13.19) 0.349 4.17 (0.58–16.95) 0.274
 pT3 55 5.76 (0.94–16.12) 0.097 6.16 (0.91–19.92) 0.090
 pT4 8 5.15 (0.77–27.71) 0.105 8.73 (0.84–20.87) 0.075
pN stage 0.101† 0.095†
 pN0 45 1.00 1.00
 pN1 28 1.97 (0.75–8.19) 0.184 2.26 (0.85–6.37) 0.159
 pN2 22 4.18 (0.89–14.42) 0.077 5.82 (0.98–16.75) 0.057
Liver metastasis
 Present 78 1.00 1.00
 Absent 17 1.91 (1.18–3.26) 0.025 2.15 (1.28–4.91) 0.017
CBS methylation
 HPM group 42 1.00 1.00
 LPM group 53 1.35 (1.09–2.41) 0.027 1.54 (1.18–3.02) 0.021

*Overall P value for pT stage.

†Overall P value for pN stage.

95% CI, 95% confidence interval; RR, risk ratio.